FDA panel recommends lifting research hold on nerve-blocking pain drugs, despite safety risk

FDA panel recommends lifting research hold on nerve-blocking pain drugs, despite safety risk

Submitted by admin on March 12, 2012 - 5:47pm
Source: 
Yahoo/AP
News Tags: 
FDA
painkillers
Pfizer
JNJ
Regeneron
arthritis
Headline: 
FDA panel recommends lifting research hold on nerve-blocking pain drugs, despite safety risk

Do Not Allow Advertisers to Use My Personal information